You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-VEGF (VEGFA) Antibodies

Full name:
anti-Vascular Endothelial Growth Factor A Antibodies (VEGFA)
On www.antibodies-online.com are 367 Vascular Endothelial Growth Factor A (VEGFA) Antibodies from 34 different suppliers available. Additionally we are shipping VEGF Proteins (126) and VEGF Kits (96) and many more products for this protein. A total of 604 VEGF products are currently listed.
Synonyms:
eVEGF120, eVEGF164, MVCD1, vefg, Vegf, VEGF-A, Vegf120, VEGF164, Vegf188, vegfa, Vpf, wu:fj82c06
list all antibodies Gene Name GeneID UniProt
VEGFA 7422 P15692
VEGFA 22339 Q00731
VEGFA 83785 P16612

Show all species

Show all synonyms

All available anti-VEGF Antibodies

Go to our pre-filtered search.

Top referenced anti-VEGF Antibodies

  1. Human Polyclonal VEGF Primary Antibody for EIA, WB - ABIN955508 : Shrivastava-Ranjan, Rollin, Spiropoulou: Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. in Journal of virology 2010 (PubMed)
    Show all 5 references for ABIN955508

  2. Human Polyclonal VEGF Primary Antibody for EIA, IHC (p) - ABIN155190 : Breier, Albrecht, Sterrer, Risau: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. in Development (Cambridge, England) 1992 (PubMed)
    Show all 3 references for ABIN155190

  3. Human Monoclonal VEGF Primary Antibody for EIA, Func - ABIN155173 : Kim, Li, Houck, Winer, Ferrara: The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. in Growth factors (Chur, Switzerland) 1992 (PubMed)
    Show all 2 references for ABIN155173

  4. Guinea Pig Polyclonal VEGF Primary Antibody for IF (p), IHC (p) - ABIN707186 : Wang, Liao, Wang, Deng, Yu: Transplantation of bone marrow stromal cells overexpressing human vascular endothelial growth factor 165 enhances tissue repair in a rat model of radiation-induced injury. in Chinese medical journal 2014 (PubMed)
    Show all 2 references for ABIN707186

  5. Human Polyclonal VEGF Primary Antibody for IF (p), IHC (p) - ABIN675893 : Ryzhov, Goldstein, Novitskiy, Blackburn, Biaggioni, Feoktistov: Role of A2B adenosine receptors in regulation of paracrine functions of stem cell antigen 1-positive cardiac stromal cells. in The Journal of pharmacology and experimental therapeutics 2012 (PubMed)

  6. Human Monoclonal VEGF Primary Antibody for IHC (p) - ABIN114925 : Turley, Scott, Watts, Bicknell, Harris, Gatter: Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. in The Journal of pathology 1999 (PubMed)

  7. Human Monoclonal VEGF Primary Antibody for Func - ABIN180646 : Brown, Berse, Jackman, Tognazzi, Guidi, Dvorak, Senger, Connolly, Schnitt: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. in Human pathology 1995 (PubMed)

More Antibodies against VEGF Interaction Partners

Zebrafish Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Methylglyoxal acts on smaller blood vessels in zebrafish via the VEGF receptor (show FLT1 Antibodies) signaling cascade, thereby describing a new mechanism that can explain vascular complications under hyperglycemia and elevated MG concentrations.

  2. The translation initiation factor eIF3i (show EIF3I Antibodies) up-regulates VEGF-A, accelerates cell proliferation, and promotes angiogenesis in embryonic development.

  3. lack of SULF1 (show SULF1 Antibodies) expression downregulates VEGFA-mediated arterial marker expression, confirming that Sulf1 (show SULF1 Antibodies) mediates arterial specification by regulating VegfA165 activity.

  4. yolk-derived 17beta-estradiol sets the ventral boundary of hemogenic vascular niche specification by antagonizing the dorsal-ventral regulatory limits of VEGF.

  5. Vegfaa has a crucial role in angiogenesis and vegfaa expression was upregulated in embryos lacking functional Pten (show PTEN Antibodies).

  6. Over expression of zebrafish vegf-a rescues Methyl tert (show TERT Antibodies)-butyl ether induced vascular lesions.

  7. Elevated Notch (show NOTCH1 Antibodies) signaling downstream of perturbed VEGF signaling contributes to aberrant flt-1 (show FLT1 Antibodies)(-/-) blood vessel formation.

  8. At the molecular level, we show that the circadian regulator Bmal1 directly targets the promoter region of the vegf gene in zebrafish, leading to an elevated expression of VEGF.

  9. Opposing effects of circadian clock genes bmal1 and period2 in regulation of VEGF-dependent angiogenesis in developing zebrafish.

  10. findings uncover a novel function for miR-1 and miR (show MYLIP Antibodies)-206 in the control of developmental angiogenesis through the regulation of VegfA, and identify a key role for miRNAs as regulators of cross-tissue signaling.

Xenopus laevis Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. VEGFA produced in the somites is required to initiate adult haemangioblast programming in the adjacent dorsal lateral plate mesoderm.

  2. sequential, isoform-specific VEGFA signaling successively induces the endothelial, arterial, and hematopoietic stem cell programs in the dorsal aorta.

  3. VEGF induces stromal cell migration or recruitment that are required for blood vessel formation.

  4. increased VEGF(170) levels disturb Hand-1 (show HAND1 Antibodies) expression in the region required for normal heart morphogenesis

Cow (Bovine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Studied the effect of cyclic uniaxial stretch (20%, 1 Hz), with and without the stimulation of vascular endothelial growth factor (VEGF), on sprouting angiogenesis by employing a stretchable three-dimensional cell culture model.

  2. Study shows that VEGFA mRNA in mammalian endothelial cells undergoes programmed translational readthrough (PTR) generating VEGF-Ax, an isoform containing a unique 22-amino-acid C terminus extension.

  3. Data indicate that superoxide dismutase (SOD) inhibited high glucose (HG)-induced expression of uPAR and VEGF in bovine retinal microvascular endothelial cell (REC).

  4. Exposure of endothelial cells to VEGF, high glucose, or hydrogen peroxide up-regulated the XBP1 (show XBP1 Antibodies)/IRE1 alpha (show ERN1 Antibodies) and ATF6 (show ATF6 Antibodies) arms of the unfolded protein response compared with untreated cells.

  5. Microvascular endothelial cells are more susceptible than aortic cells to advanced glycation end products-enhanced permeability and that AGE-enhanced permeability is dependent on VEGF expression induced by reactive oxygen species.

  6. VEGF supports germ cell survival and sperm production in bulls.

  7. analysis of polymorphisms of bovine VEGF gene and their associations with growth traits in Chinese cattle

  8. VEGF mRNA expression at estrus was higher than at the early I, early II and late luteal stages (P<0.05), whereas VEGF protein content was greatest at the early I luteal stage and decreased thereafter

  9. Alterations in the expression of VEGF-A and bFGF (show FGF2 Antibodies) systems suggest that angiogenic factors are involved in abnormal placental development in cloned gestations, contributing to impaired fetal development and poor survival rates.

  10. Advanced glycation end products increase, through a protein kinase C (show PKC Antibodies)-dependent pathway, expression in reignal endothelial cells; inhibited by gliclazide.

Human Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. oxaliplatin-based chemotherapy increases ERCC1 (show ERCC1 Antibodies) and DPYD (show DPYD Antibodies) expression levels; bevacizumab induces VEGFA expression in metastatic colorectal cancer

  2. By simulating the tumor microenvironment, the MV-delivered miR-29a/c significantly suppresses VEGF expression in gastric cancer cells, inhibiting vascular cell growth, metastasis, and tube formation.

  3. the VEGF-A ACGG haplotype from VEGF-A -2578, -1498, -1154, and -634 was significantly associated with an increased recurrence of renal cell carcinoma (show MOK Antibodies) (OR = 3.34, 95% CI = 1.03-10.91;the combination of high urinary total arsenic level and VEGF-A risk haplotypes affected the OR of renal cell carcinoma (show MOK Antibodies) recurrence in a dose-response manner.

  4. These studies demonstrate for the 1 st time that Cur-NLC exerts an antitumor effect on HepG2 cells by modulating VEGF/VEGFRs signaling pathway.

  5. FGF-2 (show FGF2 Antibodies), VEGF-A, and HIV-Tat (show TAT Antibodies), may affect the glomerular filtration barrier in HIV+ children through the induction of synergistic changes in Rho-A (show RHOA Antibodies) and Src (show SRC Antibodies) activity

  6. The modulatory role of miR (show MLXIP Antibodies)-126 on expression of VEGF-A and its tumor suppressive roles were demonstrated for the first time in thyroid cancer

  7. Data suggest that serum fetuin-A (FETUA/AHSG (show AHSG Antibodies)) concentrations are signi fi cantly positively associated with serum VEGFA (vascular endothelial growth factor A) levels in patients with newly diagnosed type 2 diabetes.

  8. This study showed an association between the VEGF -1154G/A polymorphism and RIF in Brazilian women

  9. Suggest that R-Ras regulates angiogenic activities of endothelial cells in part via inhibition of the p38MAPK-HSP27 axis of VEGF signaling.

  10. Plasma levels of VEGF were elevated in endometriosis patients compared with controls.

Mouse (Murine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Low alpha-KG levels promotes stabilization of hypoxia-induced factor 1a (Hif1a (show HIF1A Antibodies)) and secretion of vascular endothelial growth factor A (Vegfa) by starved Vldlr (show VLDLR Antibodies)(-/-) photoreceptors

  2. A2B adenosine receptor-induced VEGF production and angiogenesis are involved in myeloid-derived suppressor cells in a mouse melanoma model

  3. Our results encourage further therapeutic studies, particularly if one considers that the anti-Id therapeutic vaccination maintains stable levels of VEGF-binding antibodies, which might be useful in the control of tumor relapse.

  4. VEGFa produced in the cranial neural crest-derived mesenchyme drives proliferation, vascularization, and ossification, all of which are critical for palate development

  5. administration of 0.3 IU/mL FSH (show BRD2 Antibodies) during ovarian cryopreservation by vitrification can maintain ovarian survival during ovarian vitrification and increases the blood supply with avascular transplantation via upregulation of Cx43 (show GJA1 Antibodies), Cx37 (show GJA4 Antibodies), and VEGF/VEGFR2 (show KDR Antibodies)

  6. EMMPRIN promotes tumor growth and metastasis by recruitment of bone marrow-derived cells through controlling secretion and paracrine signaling of SDF-1 and VEGF.

  7. Identify a mechanism of VEGF overexpression in liver and mesentery that promotes pathologic, but not physiologic, angiogenesis, via sequential and nonredundant functions of CPEB1 and CPEB4.

  8. retinoic acid is produced by pulmonary endothelial cells and regulates pulmonary angiogenesis and elastin (show ELN Antibodies) synthesis by induction of VEGF-A and fibroblast growth factor (FGF)-18 (show FGF18 Antibodies), respectively

  9. The role of Hmgb1 protein in collagen antibody-induced arthritis is dependent on Vegf.

  10. Lymphomas developing in a Pde4b (show PDE4B Antibodies)-null background display significantly lower microvessel density in association with lower VEGF levels and PI3K/AKT (show AKT1 Antibodies) activity.

Pig (Porcine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Here we demonstrate that VEGF-165 mediates MSC (show MSC Antibodies) differentiation into ECs via VEGFR-2 (show KDR Antibodies)-dependent induction of Sox18 (show SOX18 Antibodies), which ultimately coordinates the transcriptional upregulation of specific markers of the EC phenotype.

  2. VEGF was significantly downregulated 7 days after cryotherapy of the sclera and stayed at that level until day 14. It returned to baseline by day 21.

  3. VEGF production, blood vessel network and follicle remodeling are impaired by the antiprogesterone RU486.

  4. findings suggest that the augmented neovascular response seen with VEGF administration was through the VEGF-induced upregulation of Notch (show NOTCH1 Antibodies) signaling.

  5. interleukin-1beta-induced vascular endothelial growth factor in airway smooth muscle cells

  6. Upregulation of VEGF during hypoxia in chondrocyte is mediated partially through HIF-1alpha (show HIF1A Antibodies).

  7. data shows that members of the VEGF-VEGFR (show KDR Antibodies) system are temporally and spatially well localized for playing key roles during umbilical cord formation and its intensive growth observed after day 75 of pregnancy

  8. cardiac-specific and hypoxia-induced coexpression of VEGF and Ang1 (show ANGPT1 Antibodies) improves the perfusion and function of porcine MI heart through the induction of angiogenesis and cardiomyocyte proliferation

  9. The mRNA for VEGFA was expressed in early developing and in maturing glomeruli.

  10. Data show that subventricular zone neural stem cells express VEGF and all VEGF splice variants, VEGFR1 (show FLT1 Antibodies), VEGFR2 (show KDR Antibodies) and Neuropilin-1 (show NRP1 Antibodies) and -2 mRNAs.

Horse (Equine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Peripheral Blood-Derived Mesenchymal Stromal Cells Promote Angiogenesis via Paracrine Stimulation of Vascular Endothelial Growth Factor Secretion

  2. TNF (show TNF Antibodies) may up-regulate VEGF and stimulate angiogenesis in the mare (show C16orf35 Antibodies) early corpus luteum.

Rabbit Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. VEGF mRNA abundance was present at low levels at 16 h post-ovulation and remained low at 72 h, but the level increased at 144 h in uterus.

  2. correlation was observed between CT perfusion parameters (BF, BV, PS, and MAV (show KLHL2 Antibodies)) and expression of VEGF and MVD (show MVD Antibodies) in tumor tissue

  3. Physiologic ischemic training stimulates VEGF-mediated mobilization of endothelial progenitor cells as well as angiogenesis.

  4. Suggest supplemental oxygen inhibits HIF-1alpha/VEGF signaling to reduce smooth muscle proliferation in rabbit arteriovenous fistula model.

  5. Therefore, it was reasonable to speculate that the increased expression of VEGF and MMP-9 (show MMP9 Antibodies) in residual hepatic tumor cells and tumor angiogenesis post-embolization would be responsible for the increased metastatic potentiality and invasiveness.

  6. VEGF expression peaked at 8 weeks after meniscus transplantation

  7. Studied the biocompatibility and neovascularization of the PLGA nanospheres wrapped with vascular endothelial growth factor (VEGF).

  8. VEGF induces TGF-beta1 (show TGFB1 Antibodies) expression and myofibroblast transformation after glaucoma surgery.

  9. The results of this study are promising concerning the role of VEGF as a diagnostic marker in moderate osteoarthritis

  10. The overexpression of VEGF increased tumor growth and vascularization, favored cyst formation, and reduced tumor necrosis.

Rhesus Monkey Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. VEGF plays an important role in choroid-retinal endothelial cell proliferation and tube formation.

  2. These findings suggest that FBLN5 (show FBLN5 Antibodies) may interfere with choroidal neovascularization by downregulating VEGF, CXCR4 (show CXCR4 Antibodies), and TGFB1 (show TGFB1 Antibodies) expression and inhibiting choroidl endothelial cell proliferation.

  3. Apelin may play a role in the development of central retinal vein occlusion (CRVO). Apelin has a unique upstream signaling pathway, independent of the VEGF pathway.

  4. Dll4 play an important role in choroidal neovascularization (CNV) angiogenesis, which appears to be regulated by HIF-1alpha and VEGF during the progression of CNV under hypoxic conditions.

  5. A functional network involving VEGF, IGF2, and MMP9 (show MMP9 Antibodies) in early placental trophoblast cells and maternal endometrium appears to be important for normal placentation.

VEGF (VEGFA) Antigen Profile

Antigen Summary

This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms.

Alternative names and synonyms associated with VEGF (VEGFA)

  • vascular endothelial growth factor Aa (vegfaa) antibody
  • vascular endothelial growth factor A (vegfa-a) antibody
  • vascular endothelial growth factor A (VEGFA) antibody
  • vascular endothelial growth factor A (vegfa) antibody
  • vascular endothelial growth factor A (Vegfa) antibody
  • eVEGF120 antibody
  • eVEGF164 antibody
  • MVCD1 antibody
  • vefg antibody
  • Vegf antibody
  • VEGF-A antibody
  • Vegf120 antibody
  • VEGF164 antibody
  • Vegf188 antibody
  • vegfa antibody
  • Vpf antibody
  • wu:fj82c06 antibody

Protein level used designations for VEGFA

VEGF-A-A , etID309976.16 , vascular endothelial growth factor A , vascular endothelial growth factor A-A , vegf-a , vascular endothelial growth factor A-a , vascular endothelial growth factor 164 , vascular permeability factor , VEGF-A , VPF , vascular endothelial growth factor 188 , angiogenic factor , Vascular permeability factor , endothelial growth factor-164 , vascular endothelial growth factor VEGF

GENE ID SPECIES
30682 Danio rerio
373589 Xenopus laevis
493845 Felis catus
100038089 Xenopus (Silurana) tropicalis
281572 Bos taurus
7422 Homo sapiens
22339 Mus musculus
83785 Rattus norvegicus
397157 Sus scrofa
403802 Canis lupus familiaris
395909 Gallus gallus
100033839 Equus caballus
443103 Ovis aries
100713483 Cavia porcellus
100860957 Capra hircus
100008899 Oryctolagus cuniculus
101839822 Mesocricetus auratus
574209 Macaca mulatta
Selected quality suppliers for anti-VEGF (VEGFA) Antibodies
Did you look for something else?